References
- Asleh R, Ward J, Levy NS, et al (2014). Haptoglobin genotypedependent differences in macrophage lysosomal oxidative injury. J Biol Chem, 23, 16313-25.
- Bertaggia E, Scabia G, Dalise S, et al (2014). Haptoglobin is required to prevent oxidative stress and muscle atrophy. PLoS One, 9, 0100745. https://doi.org/10.1371/journal.pone.0100745
- Chih-Ho Lai, Nai-Wen Chang, Chin-Fen Lin, et al (2010). Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma. Clinica Chimica Acta, 411, 984-91. https://doi.org/10.1016/j.cca.2010.03.028
- Ding Y, Xuan W, Chen C, et al (2014). Differences in carcinoembryonic antigen levels between colon and rectal cancer. Mol Clin Oncol, 2, 618-22.
- Farooqui MS, Mittal A, Poudel B, et al (2012). Improved diagnostic accuracy of pancreatic diseases with a combination of various novel serum biomarkers. Asian Pac J Cancer Prev, 13, 2171-74. https://doi.org/10.7314/APJCP.2012.13.5.2171
- Fujita K, Shimomura M, Uemura M, et al (2014). Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer. Prostate, 74, 1052-58. https://doi.org/10.1002/pros.22824
- Jessie K, Jayapalan JJ, Ong KC, et al (2013). Aberrant proteins in the saliva of patients with oral squamous cell carcinoma. Electrophoresis, 34, 2495-502. https://doi.org/10.1002/elps.201300107
- Juan HF, Chen JH, Hsu WT, et al (2004). Identification of tumorassociated plasma biomarkers using proteomic techniques; from mouse to human. Proteomics, 4, 2766-75. https://doi.org/10.1002/pmic.200400785
- Kang SM, Sung HJ, Ahn JM, et al (2011). The Haptoglobin beta chain as a supportive biomarker for human lung cancers. Mol Biosyst, 7, 1167-75. https://doi.org/10.1039/c0mb00242a
- Langlois MR, Delanghe (1996). Biological and clinical significance of haptoglobin polymorphism in hunmans. Clin Chem, 42, 1589-600.
- Lee KJ, Yi SW, Chung MJ, et al (2013). Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. Yonsei Med J, 54, 643-9. https://doi.org/10.3349/ymj.2013.54.3.643
- Melamed-Frank M, Lache O, Enav B I, et al (2001). Structurefunction analysis of the antioxidant properties of haptoglobin. Blood, 98, 3693-8. https://doi.org/10.1182/blood.V98.13.3693
- Schneider J, Bitterlich N, Velcovsky H G, et al (2005). Fuzzy logicbased tumor-marker profiles improved sensitivity in the diagnosis of lung cancer. Proteomics, 5, 4581-8. https://doi.org/10.1002/pmic.200401309
- Tan W, Wang F, Guo D, et al (2014). High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients. Int J Rheum Dis, 2014, 12380 [Epub ahead of print].
- Zhu J, Lin Z, Wu J, et al (2014). Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J Proteome Res, 13, 2986-97. https://doi.org/10.1021/pr500128t
Cited by
- Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer vol.10, pp.5, 2015, https://doi.org/10.1371/journal.pone.0126276
- Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3857
- Screening and Biosensor-Based Approaches for Lung Cancer Detection vol.17, pp.10, 2017, https://doi.org/10.3390/s17102420
- Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling vol.48, pp.3, 2016, https://doi.org/10.3892/ijo.2016.3330
- Effects of different methods of anesthesia and analgesia on immune function and serum tumor marker levels in critically ill patients vol.14, pp.3, 2017, https://doi.org/10.3892/etm.2017.4762
- Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible? vol.2018, pp.1875-8630, 2018, https://doi.org/10.1155/2018/2082840